CTI BioPharma
CTIC
#5890
Rank
ยฃ0.90 B
Marketcap
ยฃ6.87
Share price
0.00%
Change (1 day)
32.76%
Change (1 year)

CTI BioPharma (CTIC) - Total liabilities

Total liabilities on the balance sheet as of March 2023 : ยฃ0.10 Billion

According to CTI BioPharma 's latest financial reports the company's total liabilities are ยฃ0.10 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

CTI BioPharma - Total liabilities on balance sheet (from 2001 to 2023)

Total liabilities by year

Year Total liabilities Change
2022-12-31ยฃ0.11 B133.17%
2021-12-31ยฃ50.87 M280.74%
2020-12-31ยฃ13.36 M-38.2%
2019-12-31ยฃ21.61 M-25.61%
2018-12-31ยฃ29.06 M1.25%
2017-12-31ยฃ28.7 M-36.85%
2016-12-31ยฃ45.45 M-30.5%
2015-12-31ยฃ65.4 M89.23%
2014-12-31ยฃ34.56 M11.86%
2013-12-31ยฃ30.89 M22.49%
2012-12-31ยฃ25.22 M14.53%
2011-12-31ยฃ22.02 M-42.12%
2010-12-31ยฃ38.04 M-30.32%
2009-12-31ยฃ54.6 M-57.41%
2008-12-31ยฃ0.12 B40.4%
2007-12-31ยฃ91.31 M-12.08%
2006-12-31ยฃ0.10 B-31.78%
2005-12-31ยฃ0.15 B14.3%
2004-12-31ยฃ0.13 B4.21%
2003-12-31ยฃ0.12 B43.01%
2002-12-31ยฃ89.37 M-33.27%
2001-12-31ยฃ0.13 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Novartis
NVS
ยฃ60.13 B 57,744.48%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
ยฃ64.49 B 61,939.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ62.93 B 60,439.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
ยฃ10.44 B 9,949.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
ยฃ1.29 B 1,147.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ50.14 B 48,130.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ24.02 B 23,013.09%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel